Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Montevialeon Aug 12, 2017 11:49am
76 Views
Post# 26574416

RE:If Aphria is so good

RE:If Aphria is so goodBirdsplitter, I was just wondering if it was time to invest in Canopy.  I was hoping that there would be some real positive constructive feedback to some of my posts, but so far nothing other than possibly "branding" and "patient" counts.  Based on comments so far, it seems that Canopy investors are relying on these two points.  While both are valid, I'm thinking pateint counts become irrelevant when pharmacy enters the distribution chain assuming they do.  If they dont then Canopy is of to the races.  

Branding is relevant, but I think we still need to see the rules and regualtions around advertsiing before we can draw conclusion on branding strategies.  There is no doubt that Canopy as one of the first LP garnished the most media attention.  

I'm not pumping.  I'm looking for constructive criticizm on the points I raised.  It makes no difference to me where you invest your money.  I just thought you would provide me with a different perspective, but if you dont have anything useful to contribute, I'm okay with that.  


Birdsplitter wrote: Why are they over here pumping? WEED is the boss and APH has to do shady things to try to catch up. When the WEED posters show up over at APH MB then we know the tide shifted. Keep wearing yourselves out. 

Bruce is #1 and has the best brand recognition 


Bullboard Posts